Alliance Pharma (LON:APH) Share Price Crosses Below 200 Day Moving Average of $39.04

Alliance Pharma plc (LON:APHGet Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 39.04 ($0.49) and traded as low as GBX 37.10 ($0.46). Alliance Pharma shares last traded at GBX 37.25 ($0.46), with a volume of 441,309 shares changing hands.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada lowered their target price on Alliance Pharma from GBX 65 ($0.81) to GBX 60 ($0.75) and set an “outperform” rating on the stock in a research report on Wednesday, January 31st.

Check Out Our Latest Stock Report on APH

Alliance Pharma Price Performance

The company has a quick ratio of 1.42, a current ratio of 1.93 and a debt-to-equity ratio of 45.00. The business has a 50-day moving average price of GBX 39.24 and a two-hundred day moving average price of GBX 38.96. The company has a market capitalization of £197.79 million, a price-to-earnings ratio of -3,640.00, a price-to-earnings-growth ratio of 1.04 and a beta of 0.60.

Alliance Pharma Company Profile

(Get Free Report)

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.

Recommended Stories

Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.